as on November 4, 2025 at 2:29 am IST
Day's Low
Day's High
3.33%
Downside
1.67%
Upside
52 Week's Low
52 Week's High
43.03%
Downside
205.00%
Upside
Check Century Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$50.4M
EPS (TTM)
-0.2
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.12
Industry PE ratio
-0.8126129032258065
PEG Ratio
0EBITDA
-15.6M
Revenue (TTM)
114.1M
Profit Margin
-20.40%
Return On Equity TTM
-10.78%
Track how Century Therapeutics Inc P/E has moved over time to understand its valuation trends.
Century Therapeutics Inc in the last 5 years
Lowest (-5.35x)
September 30, 2022
Today (-1.12x)
November 3, 2025
Industry (-0.81x)
November 3, 2025
Highest (5.39x)
September 30, 2025
Today’s Price to Earnings Ratio: -1.12x
Compare market cap, revenue, PE, and other key metrics of Century Therapeutics Inc with its industry peers.
Company  | Analyst View | Market Cap  | 5 Years Return % | PE Ratio | Profit Margin % | 
|---|---|---|---|---|---|
| BUY | $50.4M | NA | -1.12 | -20.40% | |
| BUY | $40.4B | 478.23% | -16.34 | -264.83% | |
| BUY | $60.2B | 253.38% | 1425.12 | 1.36% | |
| BUY | $109.1B | 101.56% | 30.31 | 31.86% | |
| BUY | $68.5B | 16.98% | 15.62 | 32.13% | 
The Century Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Century Therapeutics Inc investment value today
Current value as on today
₹53,320
Returns
Returns from Century Therapeutics Inc Stock
Dollar Returns*
₹5,701 (+5.7%)
Based on 13 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Century Therapeutics Inc. Average target price of $4.25
Get share price movements and forecasts by analysts on Century Therapeutics Inc.
What analysts predicted
85.88%UPSIDE
Target Price
$4.25
Current Price
$0.6
Analyzed by
13 Analysts
Target
$4.25
Century Therapeutics Inc target price $4.25, a slight upside of 85.88% compared to current price of $0.6. According to 13 analysts rating.
Search interest for Century Therapeutics Inc Stock has increased by 41% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:41% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 4 quarters, 771.0K → 109.16M (in $), with an average increase of 59.9% per quarter
Price Rise
![]()
In the last 1 month, IPSC stock has moved up by 13.6%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 958.0% return, outperforming this stock by 1052.3%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 177.5% return, outperforming this stock by 231.2%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 76.56M → -32.54M (in $), with an average decrease of 142.5% per quarter
| Organisation | Century Therapeutics Inc | 
| Headquarters | 25 North 38th Street, Philadelphia, PA, United States, 19104 | 
| Industry | Non-Energy Minerals | 
| CEO | Dr. Brent Pfeiffenberger M.B.A., Pharm.D. | 
| E-voting on shares | Click here to vote | 
Name  | Title  | 
|---|---|
Ms. Elizabeth Devlin  | VP & Head of Development  | 
Dr. Brent Pfeiffenberger M.B.A., Pharm.D.  | President, CEO & Chairman  | 
Dr. Gregory Russotti Ph.D.  | Chief Technology & Manufacturing Officer  | 
Mr. Douglas Carr CPA  | Principal Financial Officer & Secretary  | 
Dr. Chad A. Cowan Ph.D.  | Chief Scientific Officer  | 
Michael Naso Ph.D.  | Senior VP of Cell Engineering  | 
Century Therapeutics Inc share price today is $0.6 as on at the close of the market. Century Therapeutics Inc share today touched a day high of $0.61 and a low of $0.58.
Century Therapeutics Inc share touched a 52 week high of $1.83 on and a 52 week low of $0.34 on . Century Therapeutics Inc stock price today i.e. is closed at $0.6,which is 67.21% down from its 52 week high and 75.54% up from its 52 week low.
Century Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Century Therapeutics Inc (IPSC) shares with as little as ₹88.715 or $1 (as of ) using the INDmoney app. 
      
      For example: If you want to invest $10 or ₹887.15 in Century Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). 
        Based on Century Therapeutics Inc share’s latest price of $0.6 as on November 4, 2025 at 2:29 am IST, you will get 16.6667 shares of Century Therapeutics Inc. Learn more about
          
            fractional shares .